Institutional investors purchased a net $1.1 million shares of GHDX during the quarter ended December 2013, and now own 88.11% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 198.3 Thousand shares of Genomic Health Inc
JOEL ISAACSON & CO. LLC Bought 28.8 Thousand shares of Genomic Health Inc
STANLEY-LAMAN GROUP LTD. Bought 23.1 Thousand shares of Genomic Health Inc